v3.22.2.2
DERIVATIVE FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of derivative liabilities
          
   March 31, 2022 
The financings giving rise to derivative financial instruments  Indexed
Shares
   Fair
Values
 
Compound embedded derivatives   3,418,910,016   $(3,831,191)
Total   3,418,910,016   $(3,831,191)

 

The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of March 31, 2021:

 

   March 31, 2021 
The financings giving rise to derivative financial instruments  Indexed
Shares
   Fair
Values
 
Compound embedded derivatives   347,942,680   $(1,137,623)
Total   347,942,680   $(1,137,623)

 

The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the years ended March 31, 2022 and 2021:

 

   March 31,   March 31, 
   2022   2021 
         
Compound embedded derivatives  $(1,181,178)  $(1,332,661)
Day one derivative loss   (45,485)   (151,978)
Total  $(1,226,663)  $(1,484,639)
Schedule of significant inputs
   
  March 31, 2022  
Quoted market price on valuation date $0.0025  
Contractual conversion rate $0.001512 - $0.01  
Contractual term to maturity 0.23 Years – 0.98 Years  
Market volatility:    
Equivalent Volatility 123.46% - 374.31%  
Interest rate 8.0%  
Schedule of changes in fair value of derivatives
          
   March 31,   March 31, 
   2022   2021 
         
Beginning balance  $1,137,623   $58,790 
Issuances:          
Compound embedded derivatives   2,038,843    732,416 
Conversions   (328,638)   (859,352)
Derivative extinguished / debt repaid in cash   (243,300)   (126,892)
Loss (gain) on changes in fair value inputs and assumptions reflected in income   1,181,178    1,332,661 
Day one derivative expense   45,485     
Total  $3,831,191   $1,137,623